ReviewAlzheimer's research & therapy2023

Avoiding future controversies in the Alzheimer's disease space through understanding the aducanumab data and FDA review.

Samuel P Dickson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.